✓ IROGENETICS 
L 
Report on the immune response to NYVAC-RG (vP879) in Saimiri sciureus 
monkeys (PMs&v report #MV022CRT). 
M 
Report on the virulence and antigenicity of NYVAC-RG (vP879) in the 
rabbit. Effect of route of inoculation and dose (PMs&v report 
#LV065CRT). 
N 
"Novel Poxvirus Strains as Research Tools and Vaccine Vectors", Tartaglia 
et al, AIDS RESEARCH REVIEWS , Vol. 3, Koff, Wong-Staal, Kennedy, 
eds., Marcel Dekker, Inc., New York, NY, 1993. 
0 
"Protection of Mice and Swine from Pseudorabies Virus Conferred by 
Vaccinia Virus-Based Recombinants", Riviere et al., J. Virology, 66:3424- 
3434 (1992). 
P 
Personal communication between Dr. William Mengeling, USDA National 
Animal Disease Center, and Arvilla Trag. Typed transcript of letter is 
included. Photocopy of original fax and coversheet are enclosed for 
veracity. 
Q 
Investigator’s Brochure: NYVAC-RG (vP879). This document will 
accompany our IND submission as proscribed in 21 CFR Part 312. 
R 
A letter from Dr. Cyril Gay of USDA/ APHIS, granting Virogenetics a 
Biosafety Level- 1 for a contained release involving a NYV AC-based 
Japanese Encephalitis Virus vaccine (vP908) to be administered to 150 
swine at Purdue University. The letter presents a list of the major 
considerations used in determination of the Biosafety Level- 1. 
[174] 
Recombinant DNA Research, Volume 18 
